Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression.

P Dubey1, H Wu, R E Reiter

  • 1Department of Microbiology, Howard Hughes Medical Institute, Los Angeles, CA 90095-1662, USA.

Cancer Research
|April 20, 2001
PubMed
Summary

Prostate Stem Cell Antigen (PSCA) is overexpressed in prostate cancer. This study shows PSCA is upregulated in mouse models of prostate cancer, regardless of the specific carcinogenic pathway, indicating its potential as a common therapeutic target.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analogs of the antimicrobial peptide trichogin having opposite membrane properties.

European journal of biochemistry·2001
Same author

Estimate of the frequency of true incomplete exchanges in human lymphocytes exposed to 1 GeV/u Fe ions in vitro.

International journal of radiation biology·2001
Same author

Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases.

Current biology : CB·2001
Same author

Mammotome core biopsy for mammary microcalcification: analysis of 160 biopsies from 142 women with surgical and radiologic followup.

Cancer·2001
Same author

Clinical and angiographic outcome in the laser angioplasty for restenotic stents (LARS) multicenter registry.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2001
Same author

Comparison of F ratios generated from interphase and metaphase chromosome damage induced by high doses of low- and high-LET radiation.

Radiation research·2000

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Prostate Stem Cell Antigen (PSCA) is a cell surface protein found in normal prostate tissue and overexpressed in prostate cancers.
  • Understanding how different prostate cancer development pathways influence PSCA expression is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the expression patterns of murine PSCA (mPSCA) in distinct mouse models of prostate cancer.
  • To determine if mPSCA serves as a common antigen across different prostate carcinogenesis mechanisms.

Main Methods:

  • Development of monoclonal antibodies against mPSCA.
  • Analysis of mPSCA expression in normal prostate tissue and in two distinct prostate cancer models: TRAMP and PTEN+/- mice.
  • Utilized fluorescence-activated cell sorter (FACS) analysis and immunohistochemistry.

Related Experiment Videos

Main Results:

  • mPSCA expression decreases in normal mouse prostate with age.
  • Strong mPSCA overexpression was observed in TRAMP tumors (approx. 60% of cells) compared to normal prostate.
  • Elevated mPSCA+ cells and high expression levels were detected in PTEN+/- mice prostate tumors.

Conclusions:

  • Two distinct carcinogenesis pathways (TRAMP and PTEN+/- models) converge to upregulate mPSCA expression in prostate tumors.
  • PSCA represents a common target antigen in prostate cancer, irrespective of the underlying genetic alterations.
  • These findings support PSCA as a potential pan-cancer therapeutic target for prostate cancer.